• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疑似肺结核患者唾液和血清样本中宿主生物标志物的差异表达。

Differential expression of host biomarkers in saliva and serum samples from individuals with suspected pulmonary tuberculosis.

机构信息

DST/NRF Centre of Excellence for Biomedical Tuberculosis Research and MRC Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Stellenbosch, P.O. Box 19063, Francie van Zijl Drive, Tygerberg 7505, South Africa.

出版信息

Mediators Inflamm. 2013;2013:981984. doi: 10.1155/2013/981984. Epub 2013 Nov 13.

DOI:10.1155/2013/981984
PMID:24327799
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3845251/
Abstract

The diagnosis of tuberculosis remains challenging in individuals with difficulty in providing good quality sputum samples such as children. Host biosignatures of inflammatory markers may be valuable in such cases, especially if they are based on more easily obtainable samples such as saliva. To explore the potential of saliva as an alternative sample in tuberculosis diagnostic/biomarker investigations, we evaluated the levels of 33 host markers in saliva samples from individuals presenting with pulmonary tuberculosis symptoms and compared them to those obtained in serum. Of the 38 individuals included in the study, tuberculosis disease was confirmed in 11 (28.9%) by sputum culture. In both the tuberculosis cases and noncases, the levels of most markers were above the minimum detectable limit in both sample types, but there was no consistent pattern regarding the ratio of markers in serum/saliva. Fractalkine, IL-17, IL-6, IL-9, MIP-1 β , CRP, VEGF, and IL-5 levels in saliva and IL-6, IL-2, SAP, and SAA levels in serum were significantly higher in tuberculosis patients (P < 0.05). These preliminary data indicate that there are significant differences in the levels of host markers expressed in saliva in comparison to those expressed in serum and that inflammatory markers in both sample types are potential diagnostic candidates for tuberculosis disease.

摘要

结核病的诊断在难以提供高质量痰样本的人群中仍然具有挑战性,如儿童。宿主炎症标志物的生物标志物在这种情况下可能很有价值,特别是如果它们基于更容易获得的样本,如唾液。为了探索唾液作为结核病诊断/生物标志物研究替代样本的潜力,我们评估了来自有肺结核症状的个体的唾液样本中 33 种宿主标志物的水平,并将其与血清中获得的水平进行了比较。在纳入研究的 38 名个体中,11 名(28.9%)通过痰培养确诊为结核病。在结核病病例和非病例中,大多数标志物在两种样本类型中的水平均高于最低可检测限度,但血清/唾液中标志物的比值没有一致的模式。唾液中的 fractalkine、IL-17、IL-6、IL-9、MIP-1β、CRP、VEGF 和 IL-5 水平以及血清中的 IL-6、IL-2、SAP 和 SAA 水平在结核病患者中显著升高(P<0.05)。这些初步数据表明,与血清相比,唾液中表达的宿主标志物水平存在显著差异,并且两种样本类型中的炎症标志物均是结核病疾病的潜在诊断候选物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c456/3845251/1663b0f628a2/MI2013-981984.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c456/3845251/f98f7d918adb/MI2013-981984.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c456/3845251/2d91f5056c86/MI2013-981984.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c456/3845251/13a5763c4ee7/MI2013-981984.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c456/3845251/73847b7339cc/MI2013-981984.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c456/3845251/1663b0f628a2/MI2013-981984.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c456/3845251/f98f7d918adb/MI2013-981984.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c456/3845251/2d91f5056c86/MI2013-981984.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c456/3845251/13a5763c4ee7/MI2013-981984.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c456/3845251/73847b7339cc/MI2013-981984.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c456/3845251/1663b0f628a2/MI2013-981984.005.jpg

相似文献

1
Differential expression of host biomarkers in saliva and serum samples from individuals with suspected pulmonary tuberculosis.疑似肺结核患者唾液和血清样本中宿主生物标志物的差异表达。
Mediators Inflamm. 2013;2013:981984. doi: 10.1155/2013/981984. Epub 2013 Nov 13.
2
Host biomarkers detected in saliva show promise as markers for the diagnosis of pulmonary tuberculosis disease and monitoring of the response to tuberculosis treatment.在唾液中检测到的宿主生物标志物有望作为诊断肺结核疾病和监测结核病治疗反应的标志物。
Cytokine. 2016 May;81:50-6. doi: 10.1016/j.cyto.2016.02.004. Epub 2016 Feb 13.
3
Identification of candidate host serum and saliva biomarkers for a better diagnosis of active and latent tuberculosis infection.鉴定候选宿主血清和唾液生物标志物,以更好地诊断活动性和潜伏性结核感染。
PLoS One. 2020 Jul 20;15(7):e0235859. doi: 10.1371/journal.pone.0235859. eCollection 2020.
4
Diagnostic Potential of Novel Salivary Host Biomarkers as Candidates for the Immunological Diagnosis of Tuberculosis Disease and Monitoring of Tuberculosis Treatment Response.新型唾液宿主生物标志物作为结核病免疫诊断候选物及监测结核病治疗反应的诊断潜力
PLoS One. 2016 Aug 3;11(8):e0160546. doi: 10.1371/journal.pone.0160546. eCollection 2016.
5
Suitability of saliva for Tuberculosis diagnosis: comparing with serum.唾液用于结核病诊断的适用性:与血清的比较。
BMC Infect Dis. 2017 Aug 31;17(1):600. doi: 10.1186/s12879-017-2687-z.
6
The diagnostic value of serum procalcitonin, IL-10 and C-reactive protein in community acquired pneumonia and tuberculosis.血清降钙素原、IL-10 和 C 反应蛋白在社区获得性肺炎和结核病中的诊断价值。
Eur Rev Med Pharmacol Sci. 2013 Dec;17(24):3329-33.
7
Serum inflammatory profiles in pulmonary tuberculosis and their association with treatment response.肺结核患者的血清炎症指标及其与治疗反应的关联
J Proteomics. 2016 Oct 21;149:23-30. doi: 10.1016/j.jprot.2016.06.016. Epub 2016 Jun 15.
8
Identification of novel host biomarkers in plasma as candidates for the immunodiagnosis of tuberculosis disease and monitoring of tuberculosis treatment response.鉴定血浆中新型宿主生物标志物,作为结核病免疫诊断候选物及监测结核病治疗反应。
Oncotarget. 2016 Sep 6;7(36):57581-57592. doi: 10.18632/oncotarget.11420.
9
Plasma heme oxygenase-1 levels distinguish latent or successfully treated human tuberculosis from active disease.血浆血红素氧合酶-1 水平可区分潜伏性或成功治疗的人类结核病与活动性疾病。
PLoS One. 2013 May 6;8(5):e62618. doi: 10.1371/journal.pone.0062618. Print 2013.
10
Host-Based Biomarkers in Saliva for the Diagnosis of Pulmonary Tuberculosis in Children: A Mini-Review.唾液中基于宿主的生物标志物用于儿童肺结核诊断:一项小型综述
Front Pediatr. 2021 Oct 25;9:756043. doi: 10.3389/fped.2021.756043. eCollection 2021.

引用本文的文献

1
Salivary C-Reactive Protein: A Non-Invasive Alternative to Serum CRP in Pediatric Acute Appendicitis.唾液C反应蛋白:小儿急性阑尾炎中血清CRP的一种非侵入性替代指标
Molecules. 2025 Aug 15;30(16):3392. doi: 10.3390/molecules30163392.
2
The Role of Salivary Diagnostic Techniques in Screening for Active Pulmonary Tuberculosis: A Systematic Review and Meta-Analysis.唾液诊断技术在活动性肺结核筛查中的作用:一项系统评价与荟萃分析
Microorganisms. 2025 Apr 24;13(5):973. doi: 10.3390/microorganisms13050973.
3
Insights into Autophagy in Microbiome Therapeutic Approaches for Drug-Resistant Tuberculosis.

本文引用的文献

1
Utility of host markers detected in Quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting.宿主标志物在 Quantiferon 上清液中对高负担环境中儿童结核病的诊断价值。
PLoS One. 2013 May 15;8(5):e64226. doi: 10.1371/journal.pone.0064226. Print 2013.
2
Tuberculosis biomarkers discovery: developments, needs, and challenges.结核病生物标志物的发现:进展、需求和挑战。
Lancet Infect Dis. 2013 Apr;13(4):362-72. doi: 10.1016/S1473-3099(13)70034-3. Epub 2013 Mar 24.
3
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
耐药结核病微生物组治疗方法中的自噬洞察
Cells. 2025 Apr 3;14(7):540. doi: 10.3390/cells14070540.
4
Overview of mucosal immunity and respiratory infections in children: a focus on Africa.儿童黏膜免疫与呼吸道感染概述:聚焦非洲
Curr Opin Pediatr. 2025 Apr 1;37(2):137-144. doi: 10.1097/MOP.0000000000001438. Epub 2025 Feb 5.
5
Non-sputum-based samples and biomarkers for detection of Mycobacterium tuberculosis: the hope to improve childhood and HIV-associated tuberculosis diagnosis.基于非痰液样本和生物标志物检测结核分枝杆菌:改善儿童和 HIV 相关结核病诊断的希望。
Eur J Med Res. 2024 Oct 18;29(1):502. doi: 10.1186/s40001-024-02092-z.
6
Serum Plasminogen Activator Inhibitor-1, α 1-Acid Glycoprotein, C-Reactive Protein, and Platelet Factor 4 Levels-Promising Molecules That Can Complete the "Puzzle" of the Biochemical Milieu in Severe Burns: Preliminary Results of a Cohort Prospective Study.血清纤溶酶原激活物抑制剂-1、α1-酸性糖蛋白、C反应蛋白和血小板因子4水平——有望完善重度烧伤生化环境“拼图”的分子:一项队列前瞻性研究的初步结果
J Clin Med. 2024 May 9;13(10):2794. doi: 10.3390/jcm13102794.
7
Differential levels of anti--specific IgAs in saliva of household contacts with latent tuberculosis infection.潜伏性结核感染家庭接触者唾液中抗特异性 IgA 的差异水平。
Front Med (Lausanne). 2023 Oct 6;10:1267670. doi: 10.3389/fmed.2023.1267670. eCollection 2023.
8
Advancing personalized medicine for tuberculosis through the application of immune profiling.通过免疫分析推进结核病个体化医学。
Front Cell Infect Microbiol. 2023 Feb 10;13:1108155. doi: 10.3389/fcimb.2023.1108155. eCollection 2023.
9
The Role of Salivary C-Reactive Protein in Systemic and Oral Disorders: A Systematic Review.唾液C反应蛋白在全身和口腔疾病中的作用:一项系统评价
Med J Islam Repub Iran. 2022 Nov 19;36:138. doi: 10.47176/mjiri.36.138. eCollection 2022.
10
Acute Phase Proteins Are Baseline Predictors of Tuberculosis Treatment Failure.急性期蛋白是结核病治疗失败的基线预测指标。
Front Immunol. 2021 Nov 15;12:731878. doi: 10.3389/fimmu.2021.731878. eCollection 2021.
用于检测成人肺结核和利福平耐药性的Xpert® MTB/RIF检测
Cochrane Database Syst Rev. 2013 Jan 31(1):CD009593. doi: 10.1002/14651858.CD009593.pub2.
4
Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population.评估 IP-10 和 IL-2 作为卡介苗接种人群中活动性和潜伏性结核病诊断标志物的诊断潜力。
PLoS One. 2012;7(12):e51338. doi: 10.1371/journal.pone.0051338. Epub 2012 Dec 14.
5
Immune markers and correlates of protection for vaccine induced immune responses.免疫标志物和疫苗诱导免疫应答的保护相关性。
Vaccine. 2012 Jul 13;30(33):4907-20. doi: 10.1016/j.vaccine.2012.05.049. Epub 2012 May 30.
6
Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens.当结核分枝杆菌抗原刺激结核患者的血液时,会释放多种细胞因子。
PLoS One. 2011;6(11):e26545. doi: 10.1371/journal.pone.0026545. Epub 2011 Nov 21.
7
Detection of suPAR in the Saliva of Healthy Young Adults: Comparison with Plasma Levels.健康年轻成年人唾液中可溶性尿激酶型纤溶酶原激活物受体(suPAR)的检测:与血浆水平的比较
Biomark Insights. 2011;6:119-25. doi: 10.4137/BMI.S8326. Epub 2011 Oct 25.
8
Xpert® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?Xpert® MTB/RIF 用于低收入国家的国家结核病规划:何时、何地以及如何使用?
Int J Tuberc Lung Dis. 2011 Dec;15(12):1567-72. doi: 10.5588/ijtld.11.0392. Epub 2011 Oct 13.
9
Tuberculosis assays: past, present and future.结核病检测:过去、现在和未来。
Expert Rev Anti Infect Ther. 2011 Apr;9(4):457-69. doi: 10.1586/eri.11.23.
10
Immunological biomarkers of tuberculosis.结核的免疫学生物标志物。
Nat Rev Immunol. 2011 May;11(5):343-54. doi: 10.1038/nri2960. Epub 2011 Apr 8.